This site is intended for Healthcare Professionals only
2026-05-11 10:02:32 (1 month(s) ago)
Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.
Read full MHRA article